Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 22196333)

1.

Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons.

Mazei-Robison MS, Koo JW, Friedman AK, Lansink CS, Robison AJ, Vinish M, Krishnan V, Kim S, Siuta MA, Galli A, Niswender KD, Appasani R, Horvath MC, Neve RL, Worley PF, Snyder SH, Hurd YL, Cheer JF, Han MH, Russo SJ, Nestler EJ.

Neuron. 2011 Dec 22;72(6):977-90. doi: 10.1016/j.neuron.2011.10.012.

2.

Endogenous opioid-induced neuroplasticity of dopaminergic neurons in the ventral tegmental area influences natural and opiate reward.

Pitchers KK, Coppens CM, Beloate LN, Fuller J, Van S, Frohmader KS, Laviolette SR, Lehman MN, Coolen LM.

J Neurosci. 2014 Jun 25;34(26):8825-36. doi: 10.1523/JNEUROSCI.0133-14.2014.

3.

NCAM signaling mediates the effects of GDNF on chronic morphine-induced neuroadaptations.

Li L, Cao J, Zhang S, Wang C, Wang J, Song G, Wang H, Zhang L.

J Mol Neurosci. 2014 Aug;53(4):580-9. doi: 10.1007/s12031-013-0224-0. Epub 2014 Jan 8.

PMID:
24399412
4.

BDNF is a negative modulator of morphine action.

Koo JW, Mazei-Robison MS, Chaudhury D, Juarez B, LaPlant Q, Ferguson D, Feng J, Sun H, Scobie KN, Damez-Werno D, Crumiller M, Ohnishi YN, Ohnishi YH, Mouzon E, Dietz DM, Lobo MK, Neve RL, Russo SJ, Han MH, Nestler EJ.

Science. 2012 Oct 5;338(6103):124-8. doi: 10.1126/science.1222265.

5.

IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates.

Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, Winstanley CA, Renthal NE, Wiley MD, Self DW, Russell DS, Neve RL, Eisch AJ, Nestler EJ.

Nat Neurosci. 2007 Jan;10(1):93-9. Epub 2006 Dec 3.

PMID:
17143271
6.

Self-administration of ethanol, cocaine, or nicotine does not decrease the soma size of ventral tegmental area dopamine neurons.

Mazei-Robison MS, Appasani R, Edwards S, Wee S, Taylor SR, Picciotto MR, Koob GF, Nestler EJ.

PLoS One. 2014 Apr 22;9(4):e95962. doi: 10.1371/journal.pone.0095962. eCollection 2014.

7.

No effect of morphine on ventral tegmental dopamine neurons during withdrawal.

Georges F, Le Moine C, Aston-Jones G.

J Neurosci. 2006 May 24;26(21):5720-6.

8.

Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.

Sklair-Tavron L, Shi WX, Lane SB, Harris HW, Bunney BS, Nestler EJ.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11202-7.

9.

Electroacupuncture treatment reverses morphine-induced physiological changes in dopaminergic neurons within the ventral tegmental area.

Hu L, Chu NN, Sun LL, Zhang R, Han JS, Cui CL.

Addict Biol. 2009 Sep;14(4):431-7. doi: 10.1111/j.1369-1600.2009.00163.x. Epub 2009 Jun 1.

PMID:
19489751
10.

Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids.

Labouèbe G, Liu S, Dias C, Zou H, Wong JC, Karunakaran S, Clee SM, Phillips AG, Boutrel B, Borgland SL.

Nat Neurosci. 2013 Mar;16(3):300-8. doi: 10.1038/nn.3321. Epub 2013 Jan 27.

11.

Cholinergic control of morphine-induced locomotion in rostromedial tegmental nucleus versus ventral tegmental area sites.

Wasserman DI, Wang HG, Rashid AJ, Josselyn SA, Yeomans JS.

Eur J Neurosci. 2013 Sep;38(5):2774-85. doi: 10.1111/ejn.12279. Epub 2013 Jun 17.

PMID:
23773170
12.

Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area.

Heller EA, Kaska S, Fallon B, Ferguson D, Kennedy PJ, Neve RL, Nestler EJ, Mazei-Robison MS.

J Neurochem. 2015 Jan;132(2):243-53. doi: 10.1111/jnc.12925. Epub 2014 Aug 26.

PMID:
25099208
13.

micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.

Madhavan A, He L, Stuber GD, Bonci A, Whistler JL.

J Neurosci. 2010 Mar 3;30(9):3276-86. doi: 10.1523/JNEUROSCI.4634-09.2010.

14.

Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum.

Panagis G, Kastellakis A, Spyraki C.

Psychopharmacology (Berl). 1998 Oct;139(3):222-9.

PMID:
9784077
15.

Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.

Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T.

J Neurosci. 2006 Jan 11;26(2):398-405.

16.

Morphine-induced modulation of LTD at GABAergic synapses in the ventral tegmental area.

Dacher M, Nugent FS.

Neuropharmacology. 2011 Dec;61(7):1166-71. doi: 10.1016/j.neuropharm.2010.11.012. Epub 2010 Dec 1.

PMID:
21129388
17.

Activation of alpha1-adrenoceptors enhances glutamate release onto ventral tegmental area dopamine cells.

Velásquez-Martinez MC, Vázquez-Torres R, Jiménez-Rivera CA.

Neuroscience. 2012 Aug 2;216:18-30. doi: 10.1016/j.neuroscience.2012.03.056. Epub 2012 Apr 24.

18.

Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia.

Basile AS, Fedorova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J.

Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11452-7. Epub 2002 Aug 1.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk